{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 418866747
| IUPAC_name = (''RS'')-1-[Phenyl(4-phenylphenyl)methyl]-1''H''-imidazole
| image = Bifonazole.svg
| chirality = [[Racemic_mixture|Racemic mixture]]
<!--Clinical data-->
| tradename = Canespor, many others
| Drugs.com = {{drugs.com|international|bifonazole}}
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = 
| legal_status = OTC
| routes_of_administration = Topical
<!--Pharmacokinetic data-->
| bioavailability =
| protein_bound =
| metabolism =
| elimination_half-life =
| excretion =
<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 60628-96-8
| ATC_prefix = D01
| ATC_suffix = AC10
| PubChem = 2378
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB04794
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 2287
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = QYJ305Z91O
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D01775
| ChEBI_Ref = {{ebicite|changed|EBI}}
| ChEBI = 31286
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 277535
<!--Chemical data-->
| C=22 | H=18 | N=2
| molecular_weight = 310.392 g/mol
| smiles = n1ccn(c1)C(c3ccc(c2ccccc2)cc3)c4ccccc4
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C22H18N2/c1-3-7-18(8-4-1)19-11-13-21(14-12-19)22(24-16-15-23-17-24)20-9-5-2-6-10-20/h1-17,22H
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = OCAPBUJLXMYKEJ-UHFFFAOYSA-N
}}

'''聯苯苄唑'''（Bifonazole，商標名'''Canespor''' <ref>{{drugs.com|international|bifonazole}}: Bifonazole.</ref>），音譯'''比弗那挫'''，是一種軟膏形式的[[咪唑|咪唑]][[抗真菌藥|抗真菌藥]]物。 

它於1974年獲得專利，並於1983年批准用於醫療。<ref name=Fis2006>{{cite book |last1=Fischer |first1=Jnos |last2=Ganellin |first2=C. Robin |title=Analogue-based Drug Discovery |date=2006 |publisher=John Wiley & Sons |isbn=9783527607495 |page=502 |url=https://books.google.ca/books?id=FjKfqkaKkAAC&pg=PA502 |language=en}}</ref>還有與[[尿素|尿素]]的組合用於治療[[甲癬|甲癬]]。

==副作用==
最常見的副作用是應用部位的燒灼感。其他反應如瘙癢、濕疹或皮膚乾燥，則很少見。<ref name="AC">{{cite book|title=Austria-Codex|at=Canesten Bifonazol-Creme|editor=Haberfeld, H|publisher=Österreichischer Apothekerverlag|location=Vienna|year=2015|language=de}}</ref>聯苯芐唑是一種有效的芳香酶抑製劑。<ref>{{cite journal |last1=Trösken |first1=ER |title=Inhibition of human CYP19 by azoles used as antifungal agents and aromatase inhibitors, using a new LC-MS/MS method for the analysis of estradiol product formation. |journal=Toxicology |date=2006 |volume=219(1-3) |page=33-40 |doi=10.1016/j.tox.2005.10.020 |pmid=16330141 |url=https://www.ncbi.nlm.nih.gov/pubmed/16330141}}</ref><ref>{{cite journal |last1=Egbuta |first1=C |title=Mechanism of inhibition of estrogen biosynthesis by azole fungicides |journal=Endocrinology |date=2014 |volume=155(12) |page=4622-8 |doi=10.1210/en.2014-1561 |pmid=25243857 |url=https://www.ncbi.nlm.nih.gov/pubmed/25243857}}</ref>

==參考文獻==
{{Reflist}}

* {{cite journal|pmid=2670516|title=Bifonazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses|journal=Drugs|year=1989|volume=38|issue=2|pages=204–25|author1=Lackner|first1=T. E.|last2=Clissold|first2=S. P.|doi=10.2165/00003495-198938020-00004}}

{{Antifungals}}

[[Category:酶抑制剂|Category:酶抑制剂]]
[[Category:抗真菌药物|Category:抗真菌药物]]
[[Category:咪唑|Category:咪唑]]
[[Category:联苯|Category:联苯]]
[[Category:芳香酶抑製劑|Category:芳香酶抑製劑]]